USANA Health Sciences, Inc. (NYSE: USNA) today announced
financial results for its fiscal first quarter ended April 2,
2011.
Financial Performance
Net sales in the first quarter of 2011 increased by 20.6% to
$143.6 million, compared with $119.1 million in the first quarter
of the prior year. This growth was due to higher product sales and
an increased number of active Associates driven by the Company’s
BabyCare subsidiary in China. BabyCare in the first quarter added
$5.7 million in sales and 11,000 Associates. Additionally,
favorable changes in currency exchange rates added $4.2 million in
sales.
Net earnings in the first quarter increased by 17.7% to $11.4
million, or $0.70 per share, compared with $0.62 per share in the
first quarter of the prior year. This increase resulted from
improved gross profit margins and lower relative Associate
incentive expenses. Earnings per share gains, however, were
partially offset by higher selling, general and administrative
expenses and an increased number of diluted shares outstanding.
Regional Results
Net sales in the Asia Pacific region for the first quarter of
2011 increased by 42.6% to $83.5 million, compared with the first
quarter of the prior year. This improvement was primarily due to
strong growth in Hong Kong, the Philippines, South Korea and the
addition of BabyCare. In the first quarter, the number of active
Associates in this region increased by 18.2%, which was primarily
the result of growth in Hong Kong and the Philippines, as well as
the inclusion of 11,000 BabyCare Associates.
Chief Executive Officer, Dave Wentz said, “We held our annual
Asia Pacific Convention in Hong Kong during the first quarter,
where a record 7,800 USANA Associates attended to receive training
and to learn about new regional products and incentive programs.
Sales at this event, which was held during the second quarter last
year, added $3 million dollars to the region. Most importantly,
this event provided us with an opportunity to update our Associates
on the integration of BabyCare. Another exciting announcement at
this event was the introduction of our first phase of USANA-branded
products through BabyCare. We plan to introduce additional products
into that market as we receive the required regulatory approvals.
Integrating and growing our China market will continue to be our
most significant business objective for 2011.”
During the first quarter of 2011, net sales in the North America
region decreased by 0.8% to $60.0 million, compared with the first
quarter of the prior year. The number of Active Associates in the
North America region declined by 11.7%, compared with the first
quarter of the prior year.
“Economic conditions in North America continue to present a
challenging business environment for USANA, as well as for many
other businesses in the direct selling industry,” Wentz continued.
“Although sales in this region have been flat during this economic
recession, we continue to believe that North America is crucial to
the long-term success of USANA. In an effort to improve our North
America results, we have increased our brand awareness efforts,
which we believe will make it easier for Associates to introduce
our products and business opportunity.”
Outlook
Today we are reiterating financial guidance for 2011. We
continue to project consolidated net sales to be between $530
million and $550 million and earnings per share to be between $2.85
and $2.95.
“Our first quarter financial results were consistent with our
expectations,” said Jeff Yates, Chief Financial Officer. “Beginning
in the second quarter, we will implement certain strategic changes
in Hong Kong, which are intended to promote growth in BabyCare’s
business in China. As we focus our efforts to grow China, we
anticipate that sales in Hong Kong will decline. Our estimates
suggest that we will begin to see meaningful growth in China by the
end of 2011 as we introduce additional USANA products into that
market and as our Associate leaders become more familiar with
BabyCare. We continue to believe that China remains USANA’s most
significant and imminent growth opportunity.”
Conference Call
USANA will hold a conference call and webcast to discuss this
announcement with investors on Wednesday, April 27, 2011 at 11:00
a.m. Eastern Time. Investors may listen to the call by accessing
USANA’s website at
http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high-quality nutritional,
personal care, and weight-management products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, Japan,
Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines,
the Netherlands, and the United Kingdom. Additionally, USANA’s
wholly owned subsidiary, BabyCare, Ltd., operates a direct selling
business in China. More information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
USANA Health Sciences, Inc. Consolidated
Statements of Earnings (In thousands, except per share data)
(Unaudited)
Quarter
Ended 3-Apr-10 2-Apr-11 Net
sales $ 119,087 $ 143,566 Cost of sales 23,020 25,662
Gross profit 96,067 117,904 Operating expenses
Associate incentives 54,118 64,807 Selling, general and
administrative 27,458 35,870
Earnings from
operations 14,491 17,227 Other income 339
101
Earnings before income taxes 14,830 17,328 Income
taxes 5,189 5,978
NET EARNINGS $ 9,641
$ 11,350 Earnings per share - diluted $ 0.62 $
0.70 Weighted average shares outstanding - diluted 15,513
16,217
USANA Health Sciences,
Inc. Consolidated Balance Sheets (In thousands)
As of As of 1-Jan-11 2-Apr-11
(Unaudited)
ASSETS Current Assets Cash and cash equivalents
$ 24,222 $ 32,718 Inventories 34,078 33,790 Other current assets
21,972 17,201
Total current assets 80,272
83,709 Property and equipment, net 57,568 56,800 Goodwill
16,930 16,930 Other assets 49,032 49,420
Total
assets $ 203,802 $ 206,859
LIABILITIES AND
STOCKHOLDERS' EQUITY Current liabilities Accounts payable $
6,445 $ 7,930 Other current liabilities 51,179 46,376
Total current liabilities 57,624 54,306 Other
long-term liabilities 1,012 972 Stockholders' equity 145,166
151,581
Total liabilities and stockholders' equity $
203,802 $ 206,859
USANA Health Sciences, Inc.
Sales by Region (Unaudited) (In thousands)
Quarter
Ended 3-Apr-10 2-Apr-11
Region North America United States $
37,606 31.6 % $ 37,036 25.8 % Canada 17,560 14.7 % 17,327
12.1 % Mexico 5,354 4.5 % 5,658 3.9 %
North America Total 60,520 50.8 % 60,021 41.8 % Asia Pacific
Southeast Asia/Pacific 24,533 20.6 % 24,694 17.2 %
Greater China 28,263 23.7 % 52,111 36.3 % North Asia
5,771 4.9 % 6,740 4.7 % Asia Pacific Total
58,567 49.2 % 83,545 58.2 % Consolidated $ 119,087
100.0 % $ 143,566 100.0 %
Active Associates by
Region (1) (Unaudited)
As of
3-Apr-10 2-Apr-11 Region North
America United States 56,000 27.5 % 49,000 23.0 %
Canada 25,000 12.2 % 24,000 11.3 % Mexico 13,000 6.4
% 10,000 4.7 % North America Total 94,000 46.1 %
83,000 39.0 % Asia Pacific Southeast Asia/Pacific
44,000 21.6 % 40,000 18.8 % Greater China 57,000 27.9 %
82,000 38.5 % North Asia 9,000 4.4 % 8,000 3.7
% Asia Pacific Total 110,000 53.9 % 130,000 61.0 %
Total 204,000 100.0 % 213,000
100.0 % (1) Associates are independent distributors
of our products who also purchase our products for their personal
use. We only count as active those Associates who have purchased
product at any time during the most recent three-month period,
either for personal use or for resale.
Active Preferred Customers by Region (2) (Unaudited)
As of 3-Apr-10 2-Apr-11
Region North America United States
39,000 60.0 % 38,000 54.3 % Canada 15,000 23.1 % 14,000 20.0
% Mexico 3,000 4.7 % 3,000 4.3 % North
America Total 57,000 87.8 % 55,000 78.6 % Asia Pacific
Southeast Asia/Pacific 6,000 9.2 % 6,000 8.6 %
Greater China 1,000 1.5 % 8,000 11.4 % North Asia
1,000 1.5 % 1,000 1.4 % Asia Pacific Total 8,000 12.2
% 15,000 21.4 % Total 65,000
100.0 % 70,000 100.0 %
(2) Preferred Customers purchase our
products strictly for their personal use and are not permitted to
resell or to distribute the products. We only count as active those
Preferred Customers who have purchased product at any time during
the most recent three-month period.
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024